News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
284 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17555)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (164)
2 (27)
3 (38)
4 (284)
5 (268)
6 (206)
7 (197)
8 (98)
9 (4)
10 (7)
11 (190)
12 (219)
13 (201)
14 (199)
15 (83)
16 (9)
17 (6)
18 (182)
19 (259)
20 (94)
21 (65)
22 (40)
23 (1)
24 (3)
25 (64)
26 (61)
27 (54)
28 (44)
29 (94)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Business
Eclipse Announces 2018 Medical & Scientific Advisory Board
Eclipse has announced the formation of its Medical and Scientific Advisory Board (M&SAB) for 2018.
June 4, 2018
·
3 min read
Eyecarrot to Present at the 8th Annual LD Micro Invitational
Eyecarrot Innovations Corp is pleased to announce its President and Co-founder Adam Cegielski will present at the annual LD Micro Invitational.
June 4, 2018
·
3 min read
Drug Development
Array BioPharma Announces Additional Median Overall Survival Results of Encorafenib and Binimetinib in Patients with BRAF-mutant Advanced Melanoma
Array BioPharma Inc. announced updated results from the Phase 3 COLUMBUS trial in BRAF-mutant advanced melanoma.
June 4, 2018
·
10 min read
Pharm Country
Ocean State Healthcare, a Management Services Company for Providers of Urgent Care, Primary Care and Related Healthcare Services Acquires Newport County Medical Treatment Office
Providence-based Ocean State Healthcare acquired Newport County Medical Treatment Office, a single site Urgent Care Center.
June 4, 2018
·
1 min read
Biotech Bay
Thermo Fisher Scientific Recognizes Tandem Mass Tag Grant Award Winners at ASMS 2018
International competition rewards four top proteomics researchers for outstanding innovation and impact
June 4, 2018
·
2 min read
Business
Allogene Therapeutics Appoints Alison Moore, Ph.D. as Chief Technical Officer
Dr. Moore previously served in Operations leadership roles at Amgen and Genentech.
June 4, 2018
·
4 min read
Genetown
908 Devices Expands ZipChip Application in Drug Discovery
Industry-leading Mass Spectrometers Added to Compatibility Roster
June 4, 2018
·
3 min read
Drug Development
Merck KGaA, Darmstadt, Germany Presents Updated Clinical Results for Bifunctional Immunotherapy M7824 at ASCO 2018
Merck KGaA announced results from expansion cohorts of the ongoing M7824 Phase I clinical trial (NCT02517398) program at the American Society of Clinical Oncology (ASCO) 2018 Annual Meetin.
June 4, 2018
·
8 min read
Business
Medtech Innovator Dune Medical Devices to Present at Jefferies 2018 Global Healthcare Conference
Lori Chmura will address investors at the Jefferies Global Healthcare Conference on June 8th, 12.30 ET.
June 4, 2018
·
1 min read
Drug Development
PharmaMar Presents New Results with Lurbinectedin as a Single Agent in Patients with Recurrent Small-cell Lung Cancer at ASCO 2018
PharmaMar announced new data on the recurrent small-cell lung cancer patients cohort of the phase II basket study with lurbinectedin as a single agent, will be presented at the American Society of Clinical Oncology (ASCO) annual meeting.
June 4, 2018
·
4 min read
Previous
5 of 29
Next